Literature DB >> 25446749

Extinction retention and fear renewal in a lifetime obsessive-compulsive disorder sample.

N C R McLaughlin1, D Strong2, A Abrantes1, S Garnaat1, A Cerny3, C O'Connell4, R Fadok5, C Spofford6, S A Rasmussen1, M R Milad7, B D Greenberg1.   

Abstract

Obsessive-compulsive disorder (OCD), like other illnesses with prominent anxiety, may involve abnormal fear regulation and consolidation of safety memories. Impaired fear extinction memory (extinction recall, ER) has been shown in individuals with current symptoms of OCD [1]. However, contrary to expectations, the only previous study investigating this phenomenon showed a positive correlation between extinction recall abilities and OCD symptomology (i.e., as OCD symptoms worsened, extinction memory improved). The purpose of the current study was to determine if patients with a lifetime diagnosis of OCD (not necessarily currently symptomatic) also demonstrate impairments in extinction memory, and the relationship between OCD symptomology and extinction memory in this type of sample. In addition, we also examined fear renewal, which has never been investigated in an OCD sample. We enrolled 37 patients with OCD, the majority of whom were on serotonin reuptake inhibitors, and 18 healthy control participants in a 2-day paradigm assessing fear conditioning and extinction (Day 1) and extinction retention and renewal (Day 2). Skin conductance responses (SCRs) were the dependent measure. Results, as in the prior study, indicated that the only between-group difference was impaired ER in OCD patients relative to controls. Contrary to our prediction, OCD symptom severity was not correlated with the magnitude of extinction recall. There were no differences in fear renewal between OCD patients and controls.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anxiety/anxiety disorders; Biological markers; CBT/cognitive behavior therapy; Cognition; OCD/obsessive–compulsive disorder

Mesh:

Substances:

Year:  2014        PMID: 25446749      PMCID: PMC4596815          DOI: 10.1016/j.bbr.2014.11.011

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  11 in total

1.  A twin study of the genetics of fear conditioning.

Authors:  John M Hettema; Peter Annas; Michael C Neale; Kenneth S Kendler; Mats Fredrikson
Journal:  Arch Gen Psychiatry       Date:  2003-07

2.  Chronic treatment with fluoxetine prevents the return of extinguished auditory-cued conditioned fear.

Authors:  Olivier Deschaux; Guillaume Spennato; Jean-Luc Moreau; René Garcia
Journal:  Psychopharmacology (Berl)       Date:  2010-12-22       Impact factor: 4.530

3.  Sex differences and estrous cycle in female rats interact with the effects of fluoxetine treatment on fear extinction.

Authors:  K Lebrón-Milad; A Tsareva; N Ahmed; M R Milad
Journal:  Behav Brain Res       Date:  2013-07-22       Impact factor: 3.332

Review 4.  Fear extinction as a model for translational neuroscience: ten years of progress.

Authors:  Mohammed R Milad; Gregory J Quirk
Journal:  Annu Rev Psychol       Date:  2012       Impact factor: 24.137

5.  Deficits in conditioned fear extinction in obsessive-compulsive disorder and neurobiological changes in the fear circuit.

Authors:  Mohammed R Milad; Sharon C Furtak; Jennifer L Greenberg; Aparna Keshaviah; Jooyeon J Im; Martha J Falkenstein; Michael Jenike; Scott L Rauch; Sabine Wilhelm
Journal:  JAMA Psychiatry       Date:  2013-06       Impact factor: 21.596

6.  Chronic antidepressant treatment impairs the acquisition of fear extinction.

Authors:  Nesha S Burghardt; Torfi Sigurdsson; Jack M Gorman; Bruce S McEwen; Joseph E LeDoux
Journal:  Biol Psychiatry       Date:  2012-12-20       Impact factor: 13.382

7.  Fear conditioning in panic disorder: Enhanced resistance to extinction.

Authors:  Tanja Michael; Jens Blechert; Noortje Vriends; Jürgen Margraf; Frank H Wilhelm
Journal:  J Abnorm Psychol       Date:  2007-08

8.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability.

Authors:  W K Goodman; L H Price; S A Rasmussen; C Mazure; R L Fleischmann; C L Hill; G R Heninger; D S Charney
Journal:  Arch Gen Psychiatry       Date:  1989-11

9.  Neurobiological basis of failure to recall extinction memory in posttraumatic stress disorder.

Authors:  Mohammed R Milad; Roger K Pitman; Cameron B Ellis; Andrea L Gold; Lisa M Shin; Natasha B Lasko; Mohamed A Zeidan; Kathryn Handwerger; Scott P Orr; Scott L Rauch
Journal:  Biol Psychiatry       Date:  2009-09-12       Impact factor: 13.382

10.  Deep brain stimulation of the ventral striatum enhances extinction of conditioned fear.

Authors:  Jose Rodriguez-Romaguera; Fabricio H M Do Monte; Gregory J Quirk
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

View more
  23 in total

1.  A Cross Species Approach to Understanding DBS Modulation of Fear.

Authors:  Jose Rodriguez-Romaguera; Benjamin D Greenberg; Suzanne N Haber; Gregory J Quirk
Journal:  Brain Stimul       Date:  2015-07-28       Impact factor: 8.955

2.  Behavioral and synaptic alterations relevant to obsessive-compulsive disorder in mice with increased EAAT3 expression.

Authors:  Claudia Delgado-Acevedo; Sebastián F Estay; Anna K Radke; Ayesha Sengupta; Angélica P Escobar; Francisca Henríquez-Belmar; Cristopher A Reyes; Valentina Haro-Acuña; Elías Utreras; Ramón Sotomayor-Zárate; Andrew Cho; Jens R Wendland; Ashok B Kulkarni; Andrew Holmes; Dennis L Murphy; Andrés E Chávez; Pablo R Moya
Journal:  Neuropsychopharmacology       Date:  2018-12-26       Impact factor: 7.853

3.  Heterogeneity in Fear Processing across and within Anxiety, Eating, and Compulsive Disorders.

Authors:  Abby J Fyer; Franklin R Schneier; Helen Blair Simpson; Tse Hwei Choo; Stephanie Tacopina; Marcia B Kimeldorf; Joanna E Steinglass; Melanie Wall; B Timothy Walsh
Journal:  J Affect Disord       Date:  2020-07-22       Impact factor: 4.839

4.  Can Transcranial Direct Current Stimulation Augment Extinction of Conditioned Fear?

Authors:  Mascha van 't Wout; Timothy Y Mariano; Sarah L Garnaat; Madhavi K Reddy; Steven A Rasmussen; Benjamin D Greenberg
Journal:  Brain Stimul       Date:  2016-03-09       Impact factor: 8.955

5.  Doubt and the decision-making process in obsessive-compulsive disorder.

Authors:  Gerald Nestadt; Vidyulata Kamath; Brion S Maher; Janice Krasnow; Paul Nestadt; Ying Wang; Arnold Bakker; Jack Samuels
Journal:  Med Hypotheses       Date:  2016-09-20       Impact factor: 1.538

6.  Measuring fear change within exposures: Functionally-defined habituation predicts outcome in three randomized controlled trials for pediatric OCD.

Authors:  Kristen G Benito; Jason Machan; Jennifer B Freeman; Abbe M Garcia; Michael Walther; Hannah Frank; Brianna Wellen; Elyse Stewart; Julie Edmunds; Joshua Kemp; Jeffrey Sapyta; Martin Franklin
Journal:  J Consult Clin Psychol       Date:  2018-07

7.  Neural basis of impaired safety signaling in Obsessive Compulsive Disorder.

Authors:  Annemieke M Apergis-Schoute; Claire M Gillan; Naomi A Fineberg; Emilio Fernandez-Egea; Barbara J Sahakian; Trevor W Robbins
Journal:  Proc Natl Acad Sci U S A       Date:  2017-03-06       Impact factor: 11.205

8.  Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study.

Authors:  Reilly R Kayser; Margaret Haney; Marissa Raskin; Caroline Arout; Helen Blair Simpson
Journal:  Depress Anxiety       Date:  2020-05-07       Impact factor: 6.505

Review 9.  Toward a neurocircuit-based taxonomy to guide treatment of obsessive-compulsive disorder.

Authors:  Elizabeth Shephard; Emily R Stern; Odile A van den Heuvel; Daniel L C Costa; Marcelo C Batistuzzo; Priscilla B G Godoy; Antonio C Lopes; Andre R Brunoni; Marcelo Q Hoexter; Roseli G Shavitt; Y C Janardhan Reddy; Christine Lochner; Dan J Stein; H Blair Simpson; Euripedes C Miguel
Journal:  Mol Psychiatry       Date:  2021-01-07       Impact factor: 15.992

10.  Astrocytic glutamate transporter 1 (GLT1) deficient mice exhibit repetitive behaviors.

Authors:  Yun-Fang Jia; Katheryn Wininger; Lee Peyton; Ada Man-Choi Ho; Doo-Sup Choi
Journal:  Behav Brain Res       Date:  2020-09-17       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.